Results 231 to 240 of about 351,543 (287)

Antibiotics and priority effects on colonizing resistant Escherichia coli strain assemblages in a community setting. [PDF]

PLoS One
Ng'eno E.
europepmc   +1 more source

Reperfusion‐Dependent Outcomes After Endovascular Thrombectomy Stratified by NIHSS‐ASPECTS Clinical‐Core Mismatch

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This analysis evaluates the effect of successful reperfusion on functional outcomes after MT, stratified by admission National Institutes of Health Stroke Scale (NIHSS) and Alberta Stroke Program Early CT Score (ASPECTS) as surrogates for clinical‐core mismatch, using multicenter registry data.
Felix Schlicht, Lukas Meyer, Gabriel Broocks, Matthias Bechstein, Christian Thaler, Christian Heitkamp, Laurens Winkelmeier, Vincent Geest, Alexander Heitkamp, Maximilian Jungnitz, Gregor Peter, Luca Meucci, Tobias Faizy, Jawed Nawabi, Caspar Brekenfeld, Fabian Flottmann, Maximilian Schell, Alexandros Hadjilaou, Uta Hanning, Götz Thomalla, Jens Fiehler, Susanne Gellißen, Helge C. Kniep, for the German Stroke Registry Endovascular Treatment, (GSR‐ET) Alexander Nave, Anna Alegiani, Annerose Mengel, Arno Reich, Bernd Eckert, Charlotte Pietrock, Christian Nolte, Eberhard Siebert, Fabian Flottmann, Fee Keil, Franziska Dorn, Gabor Petzold, Götz Thomalla, Hanna Zimmermann, Jan Borggrefe, Jan Hendrik Schäfer, Jens Fiehler, Joachim Röther, Klaus Gröschel, Lars Kellert, Mario Abruscato, Maximilian Schell, Omid Nikoubashman, Peter Schellinger, Silke Wunderlich, Steffen Tiedt, Sven Thonke, Timo Uphaus, Tobias Boeckh‐Behrens, Ulrike Ernemann   +53 more
wiley   +1 more source

Application of failure mode and effects analysis combined with bundled management measures in reducing ICU-acquired infections. [PDF]

Front Med (Lausanne)
Zhang M, Ku T, Jia H, Wang Y, Zhou J, Zhang W.   +5 more
europepmc   +1 more source

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

Annals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold, Krzysztof W. Selmaj, Regina Berkovich, Jeffrey A. Cohen, Giancarlo Comi, Eva K. Havrdová, James K. Sheffield, Hetal Desai, Chun‐Yen Cheng, Jon V. Riolo, Andrew Thorpe, Erik DeBoer, Bruce A. C. Cree   +12 more
wiley   +1 more source

How Hazards Turn Into Disasters: Perspectives of Emergency Responders. [PDF]

Risk Anal
Bhattacharyya A, Yonca Aydin N, Comes T.
europepmc   +1 more source

Control efficacy and groundwater risk of antibiotic resistance genes in semi-arid landfill leachate treatment: seasonal insights and engineering implications. [PDF]

Front Microbiol
Chang N, Li N, Li W, Xue J, Zheng Y, Zhao C, Zhang S, Zhang Y, Yin G, Bao M, Shen W.   +10 more
europepmc   +1 more source

Identifying Priority Outcomes for Mothers and Babies in Pregnancies With Preterm Pre-Labour Rupture of Membranes for Future Clinical Trials. [PDF]

Aust N Z J Obstet Gynaecol
Sathiyaselvan A, Dawes L, Olivier N, Manley BJ, Groom K, Whitehead CL.   +5 more
europepmc   +1 more source

A data-driven priority assessment and deployment framework for medical equipment maintenance in a tertiary hospital. [PDF]

Front Artif Intell
Ye C, Lin S, Yanjun L, Zhou P.
europepmc   +1 more source

Comment on Thomas et al. Measuring Impaired Awareness of Hypoglycemia. [PDF]

Diabetes Care
Amiel SA, Heller S, Choudhary P, Lin YK, Iqbal A.   +4 more
europepmc   +1 more source